CMR T1 mapping can track the transient myocardial tissue changes and functional impairment in COVID-19 mRNA vaccine-induced acute myocarditis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for CMR T1 mapping in mRNA vaccine myocarditis; prospective studies needed before clinical adoption.
Our patient presenting with acute myocarditis after recent COVID-19 mRNA vaccination reported a favorable clinical course. CMR revealed increased T1 mapping relaxation times diffusely spread across the myocardium and an impairment of the left ventricular function (LVEF) during the acute phase. However, the LVEF as well as the T1 times normalized at follow-up in all segments except for myocardium affected by chronic myocarditis.
No takes yet. Share an insight, caveat, or question.
Ansari et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: